| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | +2.79% | +0.98% | +1.81% | +1.94% | — |
| 14d | 4 | +0.00% | -5.18% | -0.71% | -4.47% | -4.86% | — |
| 30d | 4 | +25.00% | -21.03% | -4.97% | -16.05% | -20.74% | — |
| 60d | 4 | +0.00% | -19.11% | -0.87% | -18.24% | -21.87% | — |
| 90d | 4 | +0.00% | -30.17% | +2.79% | -32.95% | -35.99% | — |
| 180d | 4 | +0.00% | -13.72% | +12.41% | -26.13% | -28.60% | — |
| 1y | 4 | +0.00% | -41.68% | +30.91% | -72.59% | -83.23% | — |
| 2y | 4 | +25.00% | -22.05% | +29.93% | -51.98% | -59.10% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 139,000 | — | — | 139,000 | Feb 25, 2021 | Mar 1, 2021 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 64,361 | — | — | 137,535 | Feb 25, 2021 | Mar 1, 2021 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASE EVP, CSO and CMO | 4,000 | $2.20 | $8.8K | 73,174 | Sep 8, 2020 | Sep 10, 2020 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASE EVP, CSO and CMO | 2,000 | $2.88 | $5.8K | 69,174 | Aug 10, 2020 | Aug 12, 2020 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASE EVP, CSO and CMO | 5,000 | $2.88 | $14.4K | 67,174 | Aug 10, 2020 | Aug 12, 2020 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Feb 28, 2020 | Mar 3, 2020 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 62,174 | Feb 28, 2020 | Mar 3, 2020 ↗ |
| ADMA ADMA BIOLOGICS, INC. | PURCHASE CSO and CMO | 4,285 | $3.50 | $15.0K | 22,174 | Feb 11, 2020 | Feb 11, 2020 ↗ |